skip to content

Investors

Roche’s Pharma Day 2025

Roche has hosted it’s Pharma Day on 22nd September 2025 in London.

Please register to access the replay of the webcast
Presentation download

3D illustration of colorful molecules with clustered blue and red spheres on a blurred brown-orange background, conveying a scientific and dynamic feel.

Roche’s 3rd Quarter Sales 2025 Presentation

Thursday, 23 October 2025 at 14:00 CEST

More details

A gloved hand holds a pink laboratory sample above a table with three colored containers—green, blue, yellow. The scene is precise and sterile.

24 million

patients were treated with Roche medicines in 2024

30 billion

Roche Diagnostics test were delivered to customers worldwide in 2024

+1%

Core investments in research and development in 2024: CHF 13.2 billion

Product Pipeline
Why Invest

Our two divisions are focusing jointly on three disease areas that will account for almost 50% of the global disease burden by 2035: cancer, cardiovascular-metabolic diseases and neurological diseases.

Portrait of Thomas Schinecker

Dr Thomas Schinecker

CEO Roche Group

Investor updates

View all updates
View ad-hoc announcements
Subscribe

Upcoming Investor events

View all events

Bank of America Global Healthcare ConferenceInvestors

September 25, 2025 at 10:00 BST | London, UK

Add to calendar

JP Morgan CEO Conference Call SeriesInvestors

September 26, 2025 at 16:00 CEST | Basel, Switzerland

Add to calendar

Roche 3rd Quarter Sales 2025 (virtual event)Investors

October 23, 2025 at 14:00 CEST | Basel, Switzerland

Add to calendar

ZKB Swiss Equity ConferenceInvestors

November 06, 2025 at 10:00 CET | Zurich, Switzerland

Add to calendar

UBS European ConferenceInvestors

November 11, 2025 at 10:00 GMT | London, UK

Add to calendar

Guggenheim 2nd Annual Healthcare Innovation ConferenceInvestors

November 12, 2025 at 10:00 EST | Boston, US

Add to calendar

Latest reports

Smiling scientist in a lab coat and safety glasses holds a pipette in a modern laboratory. The setting conveys focus and innovation.

Half-year report 2025Investors

Microscopic image showing glowing blue cells clustered amidst intricate golden brown network, emitting a vibrant and scientific atmosphere.

Annual report 2024Investors

Finance Information Tool

Reporting

Download center

Share and Bond information

US investors

ESG Index

Investor relations team contacts

Do you need to get in touch with us? Reach out to our investor relations team with your enquiries.

View investor contact detail

Discover More

Roche Diagnostics news

Follow the most recent updates from our Diagnostics business

Genentech

Genentech has been delivering on the promise of biotechnology for over 35 years.

Sustainability at RocheAbout Roche

At Roche, our ambition lies not only in transforming healthcare, but also in our contributions to environmental protection, supply chain sustainability, social commitment and philanthropy.

Positions, policies & downloadsAbout Roche

Download our policies, guidelines, positions and other documents.

Frequently Asked QuestionsInvestors

We answer the Roche investors-related most frequently asked questions

PartneringInnovation

At Roche Partnering, we are passionate about science: yours and ours. Through partnerships, we hope that together we can build a better future with medicines that make a real difference to patients.